Crossmark

Letter to the Editor Regarding “Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis”

Crossref DOI link: https://doi.org/10.1007/s12325-024-03025-2

Published Online: 2024-11-19

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leong, Trudy D. https://orcid.org/0000-0003-2687-7751
Ebrahim, Sumayyah

Kredo, Tamara
License Information

Text and Data Mining valid from 2024-11-19

Version of Record valid from 2024-11-19
More Information

Article History

Received: 22 December 2023

Accepted: 4 October 2024

First Online: 19 November 2024

Declarations

:

: Trudy D. Leong, Sumayyah Ebrahim and Tamara Kredo have nothing to disclose.

: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below